Cannabis and cannabinoid research
A Randomized, Open-Label Trial to Assess Feasibility and Tolerability of Topical Cannabis Balms for the Treatment of Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS).
Dylan Zylla, Dame Idossa, Maria Borrero, Char Napurski, Stephen Dahmer, Jordan Cowger, Grace Gilmore, Xianghua Luo, Angela Birnbaum, Anne H Blaes
Published: 202510.1177/25785125251398286
Abstract
Introduction: Aromatase inhibitors (AIs) are commonly used for postmenopausal women with hormone receptor-positive breast cancer. Nearly two-thirds of women on AIs have arthralgias, joint stiffness, and/or bone pains referred to as aromatase inhibito…
Preview only. Read the full abstract at the source